|
|
Transarterial chemoembolization as adjuvant treatment after surgery: The cure of huge hepatocellular carcinoma? |
Andrea Chierici a , Andrew Ofosu b , Ivan Cincione c , Rodolfo Sacco d , Christian Cotsoglou a , Antonio Facciorusso d , ∗ |
a General Surgery Department, ASST-Vimercate, Vimercate 20871, Italy
b Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA 94305, United States
c Department of Clinical and Experimental Medicine, University of Foggia, Foggia 71122, Italy
d Department of Surgical and Medical Sciences, Gastroenterology Unit, University of Foggia, Viale Pinto, 1, Foggia 71122, Italy
∗ Corresponding author.
E-mail address: antonio.facciorusso@virgilio.it (A. Facciorusso). |
|
|
Abstract Hepatocellular carcinoma (HCC) represents the sixth common cancer and the second leading cause of cancer-related death. Its incidence is higher in Eastern countries. HCC is frequently detected at advanced stage of disease, and therefore, the mortality is high [1].
|
|
|
|
|
|
|
|